Physician profile
George Bekic
NPI 1235127028
$6,308.16
in general payments reported to CMS, 2019-2025
22 companies · $871 in 2025
The $871 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $928 · 2020: $230 · 2021: $1,058 · 2022: $645 · 2023: $986 · 2024: $1,592 · 2025: $871.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,205 · Consulting Fee: $148 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,205.42 |
| Consulting Fee | $148.09 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,098.25 | 2020-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $907.67 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $803.10 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $433.85 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $395.08 | 2021-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $391.08 | 2019-2024 | Eliquis, Camzyos |
| Esperion Therapeutics, INC. | $386.14 | 2021 | |
| Pfizer INC. | $384.11 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $345.36 | 2019-2024 | Farxiga |
| Heartflow, INC. | $279.56 | 2025 | |
| Shockwave Medical, INC | $178.57 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Actelion Pharmaceuticals US, INC. | $171.81 | 2024 | Opsumit, Uptravi |
| Jenavalve Technology, INC. | $148.09 | 2024 | |
| Novo Nordisk INC | $106.64 | 2025 | Wegovy, Ozempic |
| Lexicon Pharmaceuticals, INC. | $81.18 | 2023 | Inpefa |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $43.33 | 2019-2024 | |
| Abbott Laboratories | $37.02 | 2019 | |
| Irhythm Technologies, INC. | $36.61 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Kiniksa Pharmaceuticals International, Plc | $29.55 | 2024 | Arcalyst |
| Boston Scientific Corporation | $26.12 | 2025 | Avvigo Guidance System |
| Bracco Diagnostics INC. | $14.00 | 2021 | |
| Chiesi USA, INC. | $11.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Bekic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.